Understanding heart complications from COVID-19
Mechanisms of atherosclerotic cardiovascular complications in COVID19
This study is looking at how COVID-19 might cause heart issues like heart attacks and strokes even after people have recovered from the virus, by checking heart tissue from patients to see how the virus affects inflammation and heart health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10911267 on NIH RePORTER |
What this research studies
This research investigates how COVID-19 may lead to serious heart problems, such as heart attacks and strokes, even after recovery from the virus. By examining tissue from patients who had COVID-19, the researchers are looking for viral material in heart plaques and studying how it affects inflammation and disease progression. They use advanced techniques like single cell RNA sequencing to identify specific receptors that the virus interacts with in the heart. The goal is to uncover the mechanisms behind these cardiovascular complications to improve patient outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have recovered from COVID-19 and are experiencing cardiovascular symptoms or have a history of heart disease.
Not a fit: Patients who have not had COVID-19 or do not have cardiovascular issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for heart complications in COVID-19 survivors.
How similar studies have performed: Other research has indicated potential links between viral infections and cardiovascular complications, suggesting that this approach may yield valuable insights.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Giannarelli, Chiara — New York University School of Medicine
- Study coordinator: Giannarelli, Chiara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.